Skip to content
Medical Health Aged Care, Mental Health

Developing an accurate count of the domestic, family and sexual violence death toll

House of Representatives 2 mins read

The House of Representatives Standing Committee on Social Policy and Legal Affairs has established a new inquiry into the relationship between domestic, family and sexual violence (DFSV) victimisation and suicide, and how to ensure Australian governments are accurately counting the DFSV death toll.

Chair of the Committee, Ms Louise Miller-Frost MP, said: “Suicides related to DFSV victimisation are not currently counted in conventional assessments of Australia’s national DFSV crisis. This may mean that the true death toll is much higher than previously thought.”

“Developing a methodology for more accurately counting the DFSV death toll across Australian, state and territory jurisdictions could enable better policy and programs, including prevention and early intervention, and the delivery of more effectively targeted legal, justice, health, mental health, and specialist DFSV services.”

The inquiry responds to a recommendation of the Rapid Review of Prevention Approaches, which called for Australian governments to develop a consistent approach to death review processes. The Rapid Review recommended further investigation of the relationship between DFSV victimisation and suicide, with a view to developing a methodology for accurate counting of the DFSV death toll across Australian, state and territory jurisdictions. The Rapid Review said that capturing this data will enable the true scale of what the Review considers is a state of national emergency to finally be understood.

Ms Miller-Frost said: “The Committee is seeking written submissions by 30 January 2026 to inform our understanding of the relationship between DFSV victimisation and suicide, and how more accurate data and trends on DFSV deaths can be obtained.”

“The Committee is focussed on systemic issues and cannot investigate or assist with individual cases. The Committee will not be publishing contributions that provide personal details or include information relating to individual circumstances.”

Further information about the inquiry, including the full terms of reference, is available on the inquiry website at www.aph.gov.au/dfsvsuicidedata. Written submissions can be provided through the inquiry website.

Please be aware that the Committee is unable to intervene or provide advice in relation to individual circumstances. If you are in immediate danger, please contact 000. If you or someone you know needs help, please contact the services below:

  • Suicide Call Back Service:1300 659 467
  • 1800 Respect: 1800 737 732
  • Lifeline: Call 13 11 14
  • Beyond Blue: 1300 224 636
  • MensLine Australia: 1300 789 978
  • 13YARN: 13 92 76
  • Kids Helpline: 1800 551 800
  • Headspace: 1800 650 890

Media inquiries

Ms Louise Miller-Frost MP
[email protected]
0474 702 934 (Ella Grummet, media advisor)

For background information

Committee Secretariat
[email protected]
02 6277 2358 (voicemail only)

For more information about this Committee, you can visit its website: www.aph.gov.au/spla. On the site, you can make a submission to an inquiry, read other submissions, and get details for upcoming public hearings. You can also track the Committee and receive email updates by clicking on the blue ‘Track Committee’ button in the bottom right-hand corner of the page.

More from this category

  • Medical Health Aged Care
  • 22/01/2026
  • 22:11
Sinovac Biotech Ltd.

SINOVAC Announces Nasdaq Hearings Panel Grants Continued Listing

BEIJING--BUSINESS WIRE-- Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the Nasdaq Hearings Panel (the “Panel”) has granted the Company’s request to continue its listing on the Nasdaq Stock Market, subject to stated conditions focused on timely completion of its financial audit and remediation of filing delinquencies. Under the Panel’s decision, SINOVAC must, on or before May 11, 2026, demonstrate compliance with Nasdaq Listing Rule 5250(c)(1) and Listing Rule 5250(c)(2) by completing filings of its annual report for the year ended December 31, 2024 on Form 20-F and…

  • Medical Health Aged Care
  • 22/01/2026
  • 17:11
Galderma

IMCAS 2026: Galderma Showcases the Latest Scientific Advances Behind the Industry’s Broadest Injectable Aesthetics Portfolio

At IMCAS 2026, Galderma will present findings supporting Sculptra’s® regenerative properties and benefits on the body, including improving cellulite appearance, firmness, lift, projection, and…

  • Contains:
  • Medical Health Aged Care
  • 22/01/2026
  • 16:36
Dementia Australia

Get active for your brain health and beat dementia in Canberra!

The 2026 Canberra Memory Walk & Jog is just weeks away, with the event taking place on Sunday 22 February at Stage 88, Commonwealth Park. As Dementia Australia’s largest annual fundraising initiative, Memory Walk & Jog brings communities together to get active, get connected and support Australians living with dementia, their families and carers. More than 6,100 people live with dementia in the Australian Capital Territory. Dementia is now the leading cause of death for Australians, and without significant intervention, the number of Australians living with dementia is expected to increase to more than one million by 2065. In 2026,…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.